| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Regular Articles |
From the Department of Pathology,*
Emory University
Hospital, Atlanta, Georgia, and the CRC Thyroid Tumour Biology Research
Group,
Department of Pathology, University of
Wales College of Medicine, Heath Park, Cardiff, United Kingdom
Current evidence suggests the papillary thyroid carcinoma oncogene (RET/PTC) generates papillary thyroid carcinomas in one genetic step. We tested a resulting prediction that RET/PTC expression in thyroid epithelium should be sufficient to cause the changes in nuclear morphology diagnostic of this tumor. Primary cultures of human thyroid epithelial cells were infected with a RET/PTC retroviral construct. Morphological scoring by two independent cytopathologists shows RET/PTC expression by immunohistochemistry to be highly associated (p << 0.0001) with an irregular nuclear contour and a euchromatic appearance compared with non-expressing cells in the same cultures. The altered nuclear morphology is not due to gene transfer or transformation per se as primary thyroid cell cultures infected with a retroviral H-RAS construct differ from RET/PTC-infected cells by showing round nuclear envelopes and coarser chromatin, as determined by the independent scoring of two cytopathologists (p << 0.0001). In addition, RET/PTC-transfected cells appear to disperse, whereas RAS-transfected cells grow as discrete colonies. The results provide additional support for the hypothesis that RET/PTC is sufficient to cause papillary thyroid carcinomas. A signaling pathway downstream of RET/PTC leads to restructuring of the nuclear envelope and chromatin, and the signal does not depend entirely, if at all, on a RAS pathway.
This article has been cited by other articles:
![]() |
M. Santoro, R. M. Melillo, and A. Fusco RET/PTC activation in papillary thyroid carcinoma: European Journal of Endocrinology Prize Lecture. Eur. J. Endocrinol., November 1, 2006; 155(5): 645 - 653. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. G. Borrello, L. Alberti, A. Fischer, D. Degl'Innocenti, C. Ferrario, M. Gariboldi, F. Marchesi, P. Allavena, A. Greco, P. Collini, et al. Induction of a proinflammatory program in normal human thyrocytes by the RET/PTC1 oncogene PNAS, October 11, 2005; 102(41): 14825 - 14830. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. F. Louis, B. J. Vermolen, Y. Garini, I. T. Young, A. Guffei, Z. Lichtensztejn, F. Kuttler, T. C. Y. Chuang, S. Moshir, V. Mougey, et al. c-Myc induces chromosomal rearrangements through telomere and chromosome remodeling in the interphase nucleus PNAS, July 5, 2005; 102(27): 9613 - 9618. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. A. Hill, S. Chiosea, S. Jamaluddin, K. Roy, A. H. Fischer, D. D. Boyd, J. A. Nickerson, and A. N. Imbalzano Inducible changes in cell size and attachment area due to expression of a mutant SWI/SNF chromatin remodeling enzyme J. Cell Sci., November 15, 2004; 117(24): 5847 - 5854. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. H. Fischer, P. Taysavang, and S. M. Jhiang Nuclear Envelope Irregularity Is Induced by RET/PTC During Interphase Am. J. Pathol., September 1, 2003; 163(3): 1091 - 1100. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Santoro, M. Papotti, G. Chiappetta, G. Garcia-Rostan, M. Volante, C. Johnson, R. L. Camp, F. Pentimalli, C. Monaco, A. Herrero, et al. RET Activation and Clinicopathologic Features in Poorly Differentiated Thyroid Tumors J. Clin. Endocrinol. Metab., January 1, 2002; 87(1): 370 - 379. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Smyth, O. Sheils, S. Finn, C. Martin, J. O'Leary, and E. C. Sweeney Real-time Quantitative Analysis of E-cadherin Expression in ret/PTC-1-Activated Thyroid Neoplasms International Journal of Surgical Pathology, October 1, 2001; 9(4): 265 - 272. [Abstract] [PDF] |
||||
![]() |
J. Rosai Editorial: Genes and Cancer International Journal of Surgical Pathology, July 1, 2000; 8(3): 175 - 176. [PDF] |
||||
![]() |
O. M. Sheils, J. J. O'Leary, V. Uhlmann, K. Luttich, and E. C. Sweeney ret/PTC-1 Activation in Hashimoto Thyroiditis International Journal of Surgical Pathology, July 1, 2000; 8(3): 185 - 189. [Abstract] [PDF] |
||||
![]() |
C. C. Cheung, S. Ezzat, L. Ramyar, J. L. Freeman, and S. L. Asa Molecular Basis of Hurthle Cell Papillary Thyroid Carcinoma J. Clin. Endocrinol. Metab., February 1, 2000; 85(2): 878 - 882. [Abstract] [Full Text] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |